Viewing StudyNCT06180733



Ignite Creation Date: 2024-05-06 @ 7:55 PM
Last Modification Date: 2024-10-26 @ 3:16 PM
Study NCT ID: NCT06180733
Status: RECRUITING
Last Update Posted: 2023-12-22
First Post: 2023-12-04

Brief Title: Neo-adjuvant Pembrolizumab as an Alternative Treatment for MMRd Uterine Cancer
Sponsor: University Medical Center Groningen
Organization: University Medical Center Groningen

Conditions & Keywords Data

Conditions:
Name
Endometrial Cancer
Keywords:
Name View
Pembrolizumab View
Endometrial Cancer View
Uterine Cancer View
MMRd View
Grade 3 View
Clear Cell View
Neo-adjuvant View